![]() |
NKF
KDOQI GUIDELINES 2000
|
||||||
![]() |
![]() |
![]() |
![]() |
||||
General Acknowledgements
The NKF gratefully acknowledges the support of Amgen, Inc., Founding and Principal Sponsor of KDOQI, and of Luitpold Pharmaceuticals, in the KDOQI update process. We also thank Watson Pharmaceuticals, Inc., Nephrology Division (formerly Schein Pharmaceuticals, Inc.) for their support of KDOQI implementation.